Vor Biopharma (VOR) Gains from Sales and Divestitures (2022 - 2025)
Vor Biopharma (VOR) reported Gains from Sales and Divestitures of $30638.0 for Q4 2025, down 95.93% year-over-year from $752558.0 in Q4 2024, and down 95.93% quarter-over-quarter from $752558.0 in Q4 2024.
Vor Biopharma (VOR) Gains from Sales and Divestitures (2022 - 2025) Analysis & Trends
Vor Biopharma (VOR) has 4 years of Gains from Sales and Divestitures data on file, last reported at $30638.0 in Q4 2025.
- Gains from Sales and Divestitures for Q4 2025 came in at $30638.0, down 95.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $30638.0 (down 95.93% YoY), and the FY2025 annual result was $30638.0, down 95.93% from the prior year.
- Gains from Sales and Divestitures fell to $30638.0 in Q4 2025 per VOR's latest filing, from $752558.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $1.0 million in Q4 2023 and troughed at $30638.0 in Q4 2025.
- A 4-year average of $566185.5 and a median of $607129.0 in 2022 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2023 and 2025: Gains from Sales and Divestitures soared 120.89% in 2023, then plunged 95.93% in 2025.
- A 4-year view of Gains from Sales and Divestitures shows it stood at $461700.0 in 2022, then surged by 120.89% to $1.0 million in 2023, then dropped by 26.21% to $752558.0 in 2024, then sank by 95.93% to $30638.0 in 2025.
- Business Quant data shows VOR's Gains from Sales and Divestitures at $30638.0 in Q4 2025, $752558.0 in Q4 2024, and $1.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Vor Biopharma | 621.09 Mn | 621.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30,638.00 |
| Dec 31, 2025 | 30,638.00 |
| Dec 31, 2024 | 752,558.00 |
| Dec 31, 2024 | 752,558.00 |
| Dec 31, 2023 | 1.02 Mn |
| Dec 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 461,700.00 |
| Dec 31, 2022 | 461,700.00 |